Three RCTs reported overall prolactin-related adverse events, gynecomastia/galactorrhea, and amenorrhea/dysmenorrhea in patients treated with varying doses of aripiprazole and risperidone [22, 23, 26]. Here, PRL is linked to Gynecomastia.